DSM: XD scale-up can cut drug production costs
DSM Biologics says successful XD tech expansion paves way for smaller bioreactors that lowers cost of production facilities and, ultimately, of bio-drug manufacture.
CRAMS growth helps Jubilant in fiscal 2010
International demand for contract manufacturing helped India’s Jubilant Organosys finish fiscal 2010 with a quarter of growth.
DSM joins with Australian government for biologics plant
DSM Biologics has entered into a partnership with the Australian government to build a 70,000 sq ft biopharmaceutical contract manufacturing facility.
GBI, Hyprocell collaborate to offer cell line development
CMO Goodwin Biotechnology Inc (GBI) is collaborating with Hyprocell to help clients that need manufacturing services but have a sub-optimal cell line producing low concentrations.
New Xcellerex CEO targets growth in revenues, clients
The incoming Xcellerex CEO plans to move the company from validation to penetration, boosting revenues and client base, and invest in the contract manufacturing side of the business.
ACRO funds research into CROs’ role in drug development
ACRO is aiming to increase recognition and analysis of the value CROs bring to drug development, spanning their role as strategic partners throughout the process, by funding academic research.
Mircofluidics launches continuous nanocrystallisation tech
Microfluidics chose Interphex 2010 in New York, US to unveil a new processing technology that it claims can help manufacturers save time and money by switching from batch to continuous particle production.
ATMI introduces disposable bioreactor
ATMI is using Interphex 2010 to launch the Integrity PadReactor, a disposable bioreactor designed to provide a highly scalable entry point in its line of mixing and process manufacturing systems.
Ajinomoto launches scalable complex peptide synthesis
Ajinomoto AminoScience has launched AjiPhase, a peptide synthesis service which makes it practical and efficient to produce and scale up products that were previously considered too complex.
Grant given to develop continuous flow crystallisation
A project bringing together researchers from academia and pharma companies, including GSK and AZ, has received a £709,000 ($1.09m) grant to create crystals using continuous flow production.
Streamlining of Indian supply chain needed to cut costs
Rising use of biologics and a tax initiative will drive the streamlining of Indian supply chains, helping companies to deliver drugs at affordable prices, according to PwC.
Hikma to take control of Algerian joint venture
Hikma is to take full control of its Algerian joint venture in an $18.5m (€13.6m) deal, continuing its expansion in the region.
DiscoveRx adds GPCR platforms
DiscoveRx has added GPCR platforms to its portfolio, enhancing its ability to provide information on a compound’s mode of action, activated receptor recycling and efficacy in animal models.
DPT, NextPharma and Vetter update on sterile production expansions
The drug industry will gain new options for sterile contract development and manufacturing in the near future with DPT Laboratories, NextPharma and Vetter each working on new dedicated units.
Charter Medical launches single-use Bio-Pak culture bags
US group Charter Medical says its new-single use culture bags provide a stable environment that enhances cell growth and viability.